Improved technique for establishing short term human brain tumor cultures.

作者: Maxine A. Farr-Jones , Ian F. Parney , Kenneth C. Petruk

DOI: 10.1023/A:1006115608103

关键词:

摘要: Culturing human central nervous system tumors has been difficult compared to other neoplasms. We report improved success rates for establishing short term brain tumor cultures using a modified tissue processing technique. Eighty-seven specimens (56 glioblastomas, 8 mid grade astrocytomas, oligodendrogliomas, 15 other) were obtained from June 1988 March 1997. The first twenty-three samples processed by dissection, partial enzyme dissociation, and filtration through culture sieve. Subsequent identically except cells centrifuged on density gradient prior plating. Successful defined as those surviving greater than three passages in growing sufficient numbers (>106 cells) allow freezing. Success rate was 42% (10/23) standard methods 86% (55/64) with the addition of centrifugation. Glial fibrillary acidic protein (GFAP) vimentin staining, karyotypes, growth curves representative glioma cultures. All tested positive (29/29) while 62% (18/29) GFAP. Of four karyotyped (two two oligodendrogliomas), all but one oligodendroglioma exhibited clonal cytogenetic abnormalities. These immunohistochemical karyotypic results are consistent malignant glial origin these cells. note, low passage grew slower more contact inhibition immortalized glioblastoma cell lines. Nevertheless, this simple method should aid further developing pre-clinical models well enhancing clinical applications dependent vitro adjust.

参考文章(27)
Pontén J, Westermark B, Properties of human malignant glioma cells in vitro. Medical biology. ,vol. 56, pp. 184- ,(1978)
M. Westphal, M. Hänsel, H. Nausch, E. Rohde, J. Köppen, M. Fiola, F. Hölzel, H.-D. Herrmann, Glioma Biology in vitro: Goals and Concepts Proceedings of the 8th European Congress of Neurosurgery, Barcelona, September 6–11, 1987. ,vol. 43, pp. 107- 113 ,(1988) , 10.1007/978-3-7091-8978-8_23
Darell D. Bigner, Dennis E. Bullard, Joachim Mark, Peter C. Burger, Lawrence H. Muhlbaier, Sandra H. Bigner, M. Stephen Mahaley, Specific Chromosomal Abnormalities in Malignant Human Gliomas Cancer Research. ,vol. 48, pp. 405- 411 ,(1988)
A. Studer, N. de Tribolet, A. C. Diserens, A. C. Gaide, J. M. Matthieu, S. Carrel, D. Stavrou, Characterization of four human malignant glioma cell lines Acta Neuropathologica. ,vol. 66, pp. 208- 217 ,(1985) , 10.1007/BF00688585
Carol A. Kruse, Dawn H. Mitchell, Bette K. Kleinschmidt-DeMasters, Wilbur A. Franklin, Helvise G. Morse, Elaine B. Spector, Kevin O. Lillehei, Characterization of a continuous human glioma cell line DBTRG-05MG: growth kinetics, karyotype, receptor expression, and tumor suppressor gene analyses In Vitro Cellular & Developmental Biology – Plant. ,vol. 28, pp. 609- 614 ,(1992) , 10.1007/BF02631035
Iwao TAKESHITA, Tosuke TAKAKI, Masaharu KURAMITSU, Susumu NAGASAKA, Takao MACHI, Hisayuki OGAWA, Hiroto EGAMI, Hiromichi MANNOJI, Masashi FUKUI, Katsutoshi KITAMURA, Characteristics of an Established Human Glioma Cell Line, KNS-42 Neurologia Medico-chirurgica. ,vol. 27, pp. 581- 587 ,(1987) , 10.2176/NMC.27.581
J. H. Sampson, G. E. Archer, D. M. Ashley, H. E. Fuchs, L. P. Hale, G. Dranoff, D. D. Bigner, Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system Proceedings of the National Academy of Sciences of the United States of America. ,vol. 93, pp. 10399- 10404 ,(1996) , 10.1073/PNAS.93.19.10399
SANDRA H. BIGNER, DENNIS E. BULLARD, CHARLES N. PEGRAM, CAROL J. WIKSTRAND, DARELL D. BIGNER, Relationship of in vitro morphologic and growth characteristics of established human glioma-derived cell lines to their tumorigenicity in athymic nude mice. Journal of Neuropathology and Experimental Neurology. ,vol. 40, pp. 390- 409 ,(1981) , 10.1097/00005072-198107000-00004
Ian F. Parney, Kenneth C. Petruk, Chengsheng Zhang, Maxine Farr-Jones, David B. Sykes, Lung-Ji Chang, Granulocyte-macrophage colony-stimulating factor and B7-2 combination immunogene therapy in an allogeneic Hu-PBL-SCID/beige mouse-human glioblastoma multiforme model. Human Gene Therapy. ,vol. 8, pp. 1073- 1085 ,(1997) , 10.1089/HUM.1997.8.9-1073